AP
Auro Peptides Ltd
CDMO · Sangareddy (near Hyderabad), India
GMP
Overview
Auro Peptides is the peptide API unit of Aurobindo Pharma, operating a facility about 40 km from Hyderabad in Sangareddy district. It develops synthesis routes and manufactures peptides from short to long chains, and offers GMP manufacturing with regulatory support to clients. It holds active US Type II DMFs for Calcitonin, Degarelix, Desmopressin, Etelcalcetide, Ganirelix, Glatiramer, Icatibant, Leuprolide, Linaclotide, Liraglutide, Octreotide, Plecanatide, Semaglutide, Teriparatide, Vasopressin. The US FDA inspected the plant on 17-21 August 2026 and issued one observation.
Capabilities
- Generic peptide APIs
- GMP contract manufacturing
- Process development
- Regulatory dossier support
- mg-to-kg scale synthesis
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |